(Date:11/20/2009)... STOCKHOLM, November 20 Karolinska...Investment Fund (EIF) has entered into a,co-invest... fund will be,managed by Karolinska Development an...ly-stage pharmaceutical and medical technology com...he co-investment fund. The agreement,represents EI...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr....ldquo;The Role of Process Analytical Technology (P...; on December 1, 2009. , ...of Process Analytical Technology (PAT) in Green Ch... 1, Process Analytical Technology (PAT) case studi...
(Date:11/19/2009)..., Nov. 19 Omeros Corpora...nancial results for the third quarter ended Septem... 30, 2009, Omeros reported a net loss of $3.9 mill... of $7.4 million, or $2.54 per share, for the same...er 30, 2009, the Company reported a net loss of $1...
(Date:11/19/2009)...K, Nov. 19 NeoStem, Inc....ent the following letter to its shareholders, disc...009, of China Biopharmaceuticals Holdings, Inc. (C...ed in the People,s Republic of China. The merger g...Eyre Pharmaceutical Co. Ltd., CHBP,s primary opera...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3...f., Sept. 26 Corium International,Inc., a private...nnounced,that it has completed a $25.1 million Ser...ures. Quantum Technology Partners, Aphelion Capita...e round. In connection with,the financing, StrataG...,Ventures portfolio company focused on needle-free...
...6 GeoVax Labs, Inc. (OTC,Bulletin Board: GOVX), a...eceipt of an estimated $15,000,000 Integrated Prec... Grant to support its HIV/AIDS vaccine program. T...utes of,Health-National Institute of Allergy & Inf... Government. Funding commences October 2007. Only...
... of Receptor,s Central Role in Cancer is Published...demy of Sciences, MOUNTAIN VIEW, Calif., Sept. 26...utical company focused on discovering, developing,...hemokine system, today,announced the publication o...ucidate CXCR7,s essential role in the progression ...
Other Biology Technology:Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 2Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 3Corium International, Inc., Announces $40 Million Financing led by Essex Woodlands Health Ventures 4U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine Program 2U.S. Government Awards $15 Million Grant to GeoVax Labs' HIV/AIDS Vaccine Program 3ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth 2ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth 3ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth 4ChemoCentryx Demonstrates Recently Discovered Chemokine Receptor CXCR7 is Essential in Tumor Growth 5...the growing demand from the public and the scienti...kefeller University Press has revised its copyrigh...work published in its three journals. The policy, ... Rockefeller University Press journals: The Journa...icine and The Journal of General Physiology. , Th...
...h the human genome has been sequenced, research in...by the fact that most human genes have not been is...s of cancer-associated genes, the protein kinases,... cells by phosphorylating and modulating the activ...stematic gene sequencing efforts that up to a quar...
...or Oloyede said that the device, which he calls a ... surgery, eliminate unnecessary surgery, and could...determine the degree and spread of damage to the t...ch as osteo-arthritis, and other conditions which ...ment would also help in joint research and for eva...
Other Biology News:Rockefeller University Press allows authors to retain copyright to their published work 2QUT researchers develop smart instrument for tissue damage assessment 2PG 3000 Photographic Digital Printer from FUJIFILM Life Science
...is a multiplex sandwich ELISA (enzyme-linked immun...f 12 cytokines in serum; EDTA, heparin, sodium cit... the microplate provided is spotted with antibodie... samples added to the plate. After nonbound protei...
...ntegration of FRT-sites into large vector plasmids... mouse models). The included FRT-PGK-gb2-neo-FRT c...selection in prokaryotic and eukaryotic cells. It ...on of kanamycin resistance in E.coli with a euka...
Agencourt AMPure 60ml Kit from Agencourt Bioscience
Biology Products: